Related by context. All words. (Click for frequent words.) 71 Adjuvant chemotherapy 70 cisplatin chemotherapy 69 leukemia ALL 69 Torisel 69 Nexavar sorafenib 68 metastatic renal cell 68 cabazitaxel 68 Gleevec imatinib 68 leukemia AML 68 recurrent glioblastoma multiforme 68 Herceptin trastuzumab 68 recurrent colorectal cancer 68 Hodgkin lymphoma NHL 68 bevacizumab Avastin 67 Gleevec resistant 67 sorafenib Nexavar 67 erlotinib Tarceva 67 taxane chemotherapy 67 relapsed ovarian cancer 67 Jevtana 67 pancreatic NET 67 Novartis Gleevec 67 gastrointestinal stromal tumor GIST 67 imatinib Gleevec 67 metastatic gastric 67 nonsmall cell lung cancer 67 metastatic bladder 67 advanced metastatic prostate 67 metastatic renal cell carcinoma 66 hematological malignancy 66 Doxil ® 66 gemcitabine chemotherapy 66 TTF Therapy 66 mRCC 66 Rituxan rituximab 66 anthracycline taxane 66 ixabepilone 66 Tarceva erlotinib 66 cetuximab Erbitux 66 Temsirolimus 66 cytotoxic therapy 66 Alemtuzumab 66 Vandetanib 66 Pfizer Sutent 66 pemphigus vulgaris 66 Torisel temsirolimus 66 invasive candidiasis 66 Chronic lymphocytic leukemia CLL 66 acute leukemias 66 resistant hormone refractory 66 Glioblastoma Multiforme 66 TroVax ® 66 relapsed MM 65 Cloretazine 65 leukemia APL 65 Crizotinib 65 Temodar ® 65 non metastatic osteosarcoma 65 thalidomide Thalomid 65 Taxotere chemotherapy 65 Bayer Nexavar 65 recurrent metastatic 65 Hepatocellular Carcinoma HCC 65 alfa 2a 65 Arranon 65 metastatic GIST 65 malignant pleural mesothelioma 65 Hydroxyurea 65 heavily pretreated 65 lapatinib Tykerb 65 Erlotinib 65 standard chemotherapy regimens 65 receptor tyrosine kinase inhibitor 65 stage IIIB IV 65 Vidaza azacitidine 65 hormone refractory metastatic prostate 65 pediatric acute lymphoblastic 65 trastuzumab Herceptin ® 65 Riluzole 65 Surgical resection 65 cytoreduction 65 candidemia 65 Glaxo Tykerb 65 differentiated thyroid 65 acute myelogenous leukemia AML 65 Peginterferon alfa 2b 65 HER2 positive breast cancer 65 Acute myeloid leukemia 65 Myelodysplastic Syndrome MDS 65 lupus nephritis 65 Bevacizumab Avastin 65 refractory acute myeloid 65 gastrointestinal stromal tumors 65 Roche Herceptin 65 Paraplatin ® 65 Velcade bortezomib 65 Waldenstrom macroglobulinemia 64 Sorafenib 64 Sanofi Aventis Taxotere 64 basiliximab 64 allogeneic HSCT 64 mycophenolate mofetil 64 Paraplatin ® carboplatin 64 Revlimid lenalidomide 64 squamous cell lung cancer 64 basal cell carcinoma BCC 64 taxane refractory 64 paclitaxel Taxol R 64 biliary tract cancer 64 endocrine therapies 64 Merck KGaA Erbitux 64 MAGE A3 ASCI 64 tyrosine kinase inhibitors TKIs 64 taxane therapy 64 Pemetrexed 64 anthracyclines taxanes 64 interferon therapy 64 KRAS mutant tumors 64 metastatic malignant 64 dasatinib Sprycel 64 eosinophilic asthma 64 castrate resistant 64 pegylated liposomal doxorubicin 64 trabectedin 64 cancer mCRC 64 myelogenous leukemia 64 relapsing remitting MS RRMS 64 Mitoxantrone 64 galiximab 64 Fludarabine 64 HIV HCV coinfected 64 metastatic colon cancer 64 Dasatinib 64 gefitinib Iressa 64 Bezielle 64 curative therapy 64 metastatic malignant melanoma 64 TEMODAL 64 gemcitabine Gemzar 64 metastatic ovarian cancer 64 gastrointestinal stromal tumors GIST 64 Novartis Afinitor 64 lymphocytic leukemia 64 Her2 positive 64 Hormone Refractory Prostate Cancer 64 Cabazitaxel 64 relapsed ALL 64 metastatic colorectal 64 metastatic renal 64 nonmelanoma skin cancers 64 adalimumab Humira 64 anti angiogenic therapy 64 dasatinib 64 preoperative chemotherapy 64 vandetanib 64 neuroendocrine cancers 64 Aflibercept 64 Pazopanib 64 Votrient 64 Glivec imatinib 63 Taxol paclitaxel 63 docetaxel chemotherapy 63 sorafenib Nexavar ® 63 demonstrated antitumor activity 63 Hodgkin lymphoma HL 63 tumors GIST 63 recurrent genital herpes 63 grade gliomas 63 Bevacizumab 63 chemotherapeutic regimen 63 paclitaxel Taxol 63 Xelox 63 docetaxel Taxotere ® 63 cediranib 63 acute lymphoblastic 63 imatinib Gleevec ® 63 abiraterone 63 chronic HBV 63 recurrent NSCLC 63 NovoTTF 63 indolent NHL 63 infliximab Remicade 63 curative treatments 63 anticancer therapy 63 temsirolimus 63 CYT# potent vascular disrupting 63 mycosis fungoides 63 Sutent sunitinib 63 standard chemotherapy regimen 63 topotecan 63 oral clodronate 63 Irinotecan 63 Avastin bevacizumab 63 Taxotere docetaxel 63 Alessandro Riva 63 Novartis AG Gleevec 63 hypereosinophilic syndrome 63 trastuzumab DM1 63 indolent follicular non 63 smoldering myeloma 63 ZACTIMA 63 chemotherapeutic regimens 63 fallopian tube carcinoma 63 Chronic lymphocytic leukemia 63 Nilotinib 63 erlotinib Tarceva ® 63 hormonal therapies 63 olaparib 63 anti angiogenic agents 63 Basal cell 63 mapatumumab 63 anthracycline containing 63 diffuse gastric 63 gastrointestinal stromal tumor 63 Glioblastoma multiforme GBM 63 Kit CD# positive 63 Gemzar gemcitabine 63 gemifloxacin 63 postoperative chemotherapy 63 CMV disease 63 metastatic castration resistant 63 operable breast cancer 63 adult chronic ITP 63 estramustine 63 AA Amyloidosis 63 uric acid lowering 63 hepatorenal syndrome 63 Zolinza 63 hepatic metastases 63 metastatic lung cancer 63 myelodysplastic syndrome MDS 63 Flu Cy 63 vemurafenib 63 Cetuximab 63 hormone refractory 63 AstraZeneca Iressa 63 azacitidine 62 smoldering multiple myeloma 62 chemotherapy cisplatin 62 BRAF V# mutation 62 refractory metastatic 62 myelodysplastic myeloproliferative diseases 62 skeletal metastases 62 MabThera Rituxan 62 Gefitinib 62 corticosteroid therapy 62 stage IIIb IV 62 5 fluorouracil leucovorin 62 SJIA 62 nonmetastatic 62 bevacizumab Avastin ® 62 surgical debulking 62 Femara letrozole 62 metastatic RCC 62 EGFR mutation positive 62 Folfox 62 medullary thyroid cancer 62 Noxafil 62 Pegylated Interferon 62 irinotecan chemotherapy 62 relapsed SCLC 62 refractory Hodgkin 62 chronic lymphocytic leukemia CLL 62 paclitaxel cisplatin 62 Fludara ® 62 Gleevec imatinib mesylate 62 lenalidomide Revlimid R 62 Hurthle cell 62 chlorambucil 62 paclitaxel Taxol ® 62 idiopathic pulmonary fibrosis IPF 62 mTOR inhibitor 62 investigational monoclonal antibody 62 homozygous familial hypercholesterolemia 62 Menopausal hormone therapy 62 androgen independent 62 Alimta pemetrexed 62 androgen ablation 62 alkylating agent 62 TORISEL 62 MGd 62 nilotinib 62 Roche Xeloda 62 antimetabolite 62 eflornithine 62 medically inoperable 62 gemcitabine carboplatin 62 Lapatinib 62 EGFR inhibitors 62 Sprycel dasatinib 62 invasive aspergillosis 62 recurrent glioblastoma 62 pertuzumab 62 Azacitidine 62 refractory indolent non 62 AVASTIN 62 Lilly Gemzar 62 adriamycin 62 cardiotoxic 62 Lenalidomide 62 vinca alkaloids 62 Tarceva TM 62 relapsed leukemia 62 Golimumab 62 systemic ALCL 62 recurrent ovarian cancer 62 cirrhosis liver failure 62 Combination therapy 62 haematologic 62 metastatic melanoma 62 HER2 positive cancers 62 leukemia CLL 62 refractory chronic lymphocytic 62 advanced HER2 positive 62 Anthracycline 62 refractory myeloma 62 antiestrogen 62 pegylated interferon alpha 62 cyclophosphamide chemotherapy 62 hormone deprivation 62 Sunitinib 62 docetaxel Taxotere 62 prostate adenocarcinoma 62 leukaemias 62 Fulvestrant 62 Acute Myeloid Leukemia AML 62 Annamycin 62 SPRYCEL ® 62 autoantibody positive 62 BRAF inhibitor 62 decitabine 62 Idiopathic Pulmonary Fibrosis IPF 62 refractory ovarian cancer 62 nucleotide analogue 62 sunitinib Sutent 62 ATTR PN 62 Metastatic Colorectal Cancer 62 FUSILEV enhances 62 seminoma 62 C1 INH deficiency 62 evaluating tivozanib 62 Squamous 62 FOLFIRI alone 62 Rilutek 62 sorafenib tablets 62 Mylotarg 62 refractory AML 62 GISTs 62 adjuvant cisplatin 62 gastrointestinal stromal 62 Chronic Myeloid Leukemia 62 Neuvenge 62 Platinol ® 62 androgen suppression therapy 62 EGFR TKI 62 doxorubicin Adriamycin 62 UCB Cimzia 62 Tykerb lapatinib 62 cytotoxic chemotherapy 62 Certolizumab pegol 62 diabetic kidney 62 infusional 5-FU/LV 61 Gleevec Glivec 61 MyVax R 61 LHRH receptor positive 61 blastic phase 61 Trastuzumab 61 unresectable stage 61 hematopoietic cancers 61 MCyR 61 temozolomide TMZ 61 atypical hemolytic uremic syndrome 61 Hycamtin 61 antiandrogen 61 pegfilgrastim 61 prostate cancer HRPC 61 bladder ovarian 61 #mg ATC 61 complete cytogenetic response 61 untreated metastatic colorectal 61 esophageal candidiasis 61 chemoradiotherapy 61 bortezomib Velcade 61 lumiliximab 61 plus dexamethasone 61 Gleevac 61 grade cervical intraepithelial 61 ACTEMRA TM 61 autologous transplants 61 heavily pretreated patients 61 Taxotere ® 61 non squamous NSCLC 61 Topotecan 61 malignant ascites 61 riociguat 61 Vidaza ® 61 acute myeloid 61 CCyR 61 myelofibrosis polycythemia vera 61 rituximab Rituxan 61 Abacavir 61 squamous non 61 adjuvant radiotherapy 61 DFMO 61 pancreatic neuroendocrine tumors 61 HERCEPTIN 61 dirucotide MBP# 61 Metastatic breast cancer 61 Ribavirin causes 61 intravenous cyclophosphamide 61 advanced hepatocellular carcinoma 61 K ras mutations 61 carcinoid tumors 61 Ceflatonin 61 HER2 overexpression 61 idarubicin 61 opioid induced constipation OIC 61 recurrent glioblastoma multiforme GBM 61 ara C 61 Follicular Lymphoma 61 adjuvant tamoxifen 61 Imatinib 61 Zarnestra 61 immunodeficiency disorders 61 Idiopathic pulmonary fibrosis 61 canakinumab 61 epithelial tumors 61 Iressa gefitinib 61 LHRH analogues 61 potentially hepatotoxic 61 rufinamide 61 carcinoid 61 grade serous ovarian 61 Lung transplantation 61 Tasigna nilotinib 61 cisplatin resistant 61 curative resection 61 malignant brain 61 ano genital warts 61 methotrexate therapy 61 SUPPRELIN R LA 61 endometrial cancers 61 advanced medullary thyroid 61 Capecitabine 61 PKC# 61 placebo dexamethasone 61 liver metastasis 61 TTR amyloidosis 61 Genentech Rituxan 61 herceptin 61 Brain metastases 61 chronic idiopathic thrombocytopenic purpura 61 dasatinib Sprycel ® 61 Degarelix 61 Myelofibrosis 61 follicular lymphoma FL 61 cardiotoxicity 61 cisplatin gemcitabine 61 Malignant Melanoma 61 chronic eosinophilic leukemia 61 ® lenalidomide 61 malignant neoplasm 61 interferon alfa 2b 61 tamoxifen Nolvadex ® 61 refractory chronic myeloid 61 Follicular lymphoma 61 oxaliplatin Eloxatin 61 Campath alemtuzumab 61 Bosentan 61 adverse cytogenetics 61 flutamide 61 Camptosar ® 61 relapsing multiple sclerosis 61 receiving immunosuppressive therapy 61 non squamous 61 lenalidomide dexamethasone 61 castrate resistant prostate cancer 61 previously untreated follicular 61 prostate cancer CRPC 61 radiation sensitizer 61 multi kinase inhibitor 61 axitinib 61 Amrubicin 61 deletion 5q 61 colorectal cancer liver metastases 61 antiarrhythmic drugs 61 bone metastasis 61 Acute Myelogenous Leukemia AML 61 Leukemias 61 Aplidin 61 Telintra 61 5-FU/LV 61 panitumumab Vectibix 61 Recombinant interferon alpha 61 Adjuvant Treatment 61 recurrent malignant glioma 61 fluorouracil leucovorin 61 GW# [003] 61 locoregional 61 Axitinib 61 Gemcitabine 61 chronic granulomatous disease 61 refractory gout 61 goserelin 61 stage IIIB 61 sunitinib malate 61 metastatic hormone refractory 61 calcineurin inhibitor 60 neovascular diseases 60 YONDELIS 60 refractory metastatic colorectal cancer 60 neoadjuvant treatment 60 Epratuzumab 60 clinically localized prostate 60 diabetic gastroparesis 60 Roche Actemra 60 allogeneic transplantation 60 SNT MC# 60 immune suppressing medication 60 relapsed multiple myeloma 60 treating neuropathic pain 60 Faslodex 60 cranial irradiation 60 TNF alpha antagonist 60 anti EGFR antibody 60 Seliciclib 60 panobinostat 60 gastrointestinal stromal tumors GISTs 60 anaplastic astrocytoma 60 rituximab refractory 60 anthracycline therapy 60 temozolomide Temodar 60 myelodysplastic syndromes 60 interferon ribavirin 60 calcineurin inhibitors 60 BARACLUDE ® 60 eribulin mesylate 60 assessing T DM1 60 Paxil paroxetine 60 radiation chemoradiation 60 efalizumab 60 de novo AML 60 HER2 positive breast 60 tocilizumab 60 Trastuzumab Herceptin 60 systemic fungal infections 60 vincristine doxorubicin 60 HER2 positive metastatic breast 60 mitoxantrone plus 60 malignant pleural mesothelioma MPM 60 BEACOPP 60 Avastin 60 Abiraterone acetate 60 nucleoside analogs 60 Glioblastoma Multiforme GBM 60 nonnucleoside reverse transcriptase inhibitors 60 TNF inhibitors 60 neoadjuvant therapy 60 ZACTIMA TM ZD# 60 Oxaliplatin 60 tyrosine kinase inhibitor 60 colorectal liver metastases 60 Pirfenidone 60 precancerous condition 60 hepatocellular cancer 60 de novo kidney transplant 60 BCR ABL inhibitor 60 castration resistant 60 Yervoy 60 Allovectin 7 60 glioblastoma multiforme GBM 60 Fingolimod 60 pegylated interferon alfa 60 Genasense ® 60 ELACYT 60 HBeAg negative 60 curable cancers 60 immune suppressing 60 GnRH agonists 60 Candida infections 60 Chronic Myelogenous Leukemia CML 60 Uterine cancer 60 chemopreventive agent 60 humanised monoclonal antibody 60 AML acute myeloid 60 antiangiogenic therapy 60 plus dacarbazine 60 Hurler syndrome 60 advanced metastatic renal 60 steroid refractory GvHD 60 Cytoxan 60 TNF antagonist 60 colorectal lung 60 HRPC 60 docetaxel Taxotere R 60 ImClone Erbitux 60 Pulmonary hypertension 60 TORISEL TM 60 prolongs survival 60 taxotere 60 Isentress raltegravir 60 Etanercept 60 Anastrozole 60 refractory colorectal cancer 60 TKI therapy 60 IMA# 60 hypercholesterolemic patients 60 eribulin 60 cyclophosphamide Cytoxan 60 Reminyl galantamine 60 prior chemotherapy regimens 60 Pegasys peginterferon alfa 2a 60 chronic thromboembolic pulmonary 60 Allovectin 7 ® 60 Acute Myeloid Leukemia 60 Acute Myelogenous Leukemia 60 Abatacept 60 cetuximab Erbitux R 60 amrubicin 60 fluoropyrimidine 60 MKC# MT 60 bendamustine 60 Cutaneous T 60 untreated chronic lymphocytic 60 malignant lymphomas 60 antibody MAb 60 resected pancreatic cancer 60 refractory prostate cancer 60 hypercalcemia 60 Zytiga 60 childhood acute lymphoblastic 60 inoperable pancreatic cancer 60 Anaplastic 60 recurrent GBM 60 Liver transplantation 60 Aviptadil 60 Epivir 60 BRAF mutations 60 stage IIIA 60 Cellcept 60 serologically active systemic lupus 60 Revlimid 60 microtubule inhibitor 60 motesanib 60 noninfectious uveitis 60 unresectable tumors 60 atherothrombotic events 60 macrolide antibiotic 60 refractory CTCL 60 amoxicillin clavulanate 60 APTIVUS R 60 bleomycin 60 cytopenias 60 cutaneous melanoma 60 EFAPROXYN 60 recurrent myocardial infarction 60 ErbB2 positive 60 proteasome inhibitor 60 Erbitux cetuximab 60 Rilonacept 60 remission induction 60 adjuvant colon cancer 60 lymphoid malignancies 60 alefacept 60 MIRAPEX ER 60 Muraglitazar 60 R sorafenib tablets 60 cytogenetic responses 60 drug Treanda 60 juvenile idiopathic arthritis JIA 60 oropharyngeal candidiasis OPC 60 Arzerra 60 PCNSL 60 vismodegib 60 Xanafide 60 complement inhibitor eculizumab 60 Platinol ® cisplatin 60 Nexavar tablets 60 alemtuzumab treated 60 XELOX 60 bladder cancers 60 pelvic malignancies 60 acute promyelocytic leukemia APL 60 Acute Myeloid Leukaemia AML 60 refractory epilepsy 60 ZOLINZA 60 Clofarabine 60 FOLFOX6 60 Sutent 60 Troxatyl 60 Toxicities 60 iniparib 60 invasive lobular 60 sunitinib 60 cilengitide 60 deferiprone 60 Decitabine 60 protease inhibitor PI 60 antiemetics 60 aflibercept VEGF Trap 60 Biogen Idec Avonex 60 Laquinimod 60 LHRH agonists 60 Neoadjuvant 60 Bleomycin 60 Tygacil 60 Rituximab 60 long acting bronchodilator 60 CHOP chemotherapy 60 antithrombotic therapy 60 OncoVEX GM CSF 60 Advagraf 60 pancreatic carcinoma 60 cranial radiation 60 Novantrone 60 castration resistant hormone refractory 60 leukemias lymphomas 60 CTAP# Capsules 60 alvespimycin 60 Brentuximab Vedotin SGN 60 Acute myelogenous leukemia 60 Hycamtin ® 60 active ankylosing spondylitis 60 EndoTAGTM 1 60 pancreatic lung 60 systemic scleroderma 60 Docetaxel 59 thetreatment 59 cetuximab Erbitux ® 59 transplantation HCT 59 multiple myeloma MM 59 Romiplostim 59 pCR 59 Ixempra 59 GVAX 59 grade cervical dysplasia 59 Plaquenil 59 Cell Lymphoma CTCL 59 decompensated liver disease 59 Onrigin 59 Panitumumab 59 alkylating agents 59 ductal breast cancer 59 colorectal breast 59 neoadjuvant chemotherapy 59 endometrial hyperplasia 59 ribavirin therapy 59 PEG interferon 59 Relapsing remitting MS 59 Infusion reactions 59 omega interferon 59 leukoencephalopathy 59 aromatase inhibitors AIs 59 aldosterone antagonists 59 FIRMAGON 59 Cimzia TM 59 Tolamba 59 PTLD 59 sorafenib 59 intra arterial chemotherapy 59 androgen deprivation 59 hepatic toxicity 59 corticosteroid dexamethasone 59 intravenous bisphosphonates 59 Ophena TM 59 TELINTRA 59 underwent surgical resection 59 Xeloda capecitabine 59 achieved CCyR 59 Renal Cell Carcinoma 59 Roche Avastin 59 MGUS 59 alpha interferons 59 tamoxifen therapy 59 enzastaurin 59 Testicular cancer 59 acute GvHD 59 metastatic castrate resistant 59 nevirapine Viramune 59 Fludara 59 peritoneal cancer 59 relapsed acute lymphoblastic 59 lung cancer NSCLC 59 Glioblastoma multiforme 59 interstitial pneumonitis 59 hematologic disorders 59 Progressive Multifocal Leukoencephalopathy 59 achieved sustained virological 59 VIDAZA 59 imatinib therapy 59 Arcalyst 59 atypical antipsychotic medication 59 oxypurinol 59 cutaneous squamous cell carcinoma 59 systemic corticosteroid 59 fluorouracil 59 Proleukin 59 unresectable recurrent 59 receiving highly emetogenic 59 Peg IFN 59 ximelagatran 59 PSMA ADC 59 kidney urologic 59 Myelodysplastic syndromes MDS 59 miglustat 59 inhaled bronchodilators 59 Sudhir Agrawal D.Phil 59 chronic GVHD 59 immunomodulatory agents 59 DOXIL 59 methotrexate monotherapy 59 Everolimus 59 paroxetine Paxil 59 lenalidomide Revlimid 59 AML MDS 59 TREANDA 59 nephrotoxicity 59 myeloablative 59 invasive ductal 59 Actimmune ® 59 GvHD 59 forodesine 59 Severe Sepsis 59 5-fluorouracil/leucovorin 59 metastatic pancreatic 59 stage IIIb 59 Afatinib 59 radiofrequency ablation RFA 59 capecitabine Xeloda 59 renal cell carcinoma 59 EGFR tyrosine kinase inhibitors 59 Intravenous CP 59 Idiopathic Pulmonary Fibrosis 59 SUTENT 59 DMARD therapy 59 FOLFOX chemotherapy 59 taxane chemotherapy administered 59 proliferative retinopathy 59 AA amyloidosis 59 severe oral mucositis 59 interferon gamma 1b 59 Pegintron 59 Myelodysplastic Syndrome 59 TNF blocker 59 mutated KRAS 59 Cytarabine 59 localized renal 59 denileukin diftitox 59 haloperidol Haldol 59 Accutane isotretinoin 59 ganciclovir 59 chemotherapies 59 Evoltra ® 59 Kinoid 59 homozygous FH 59 nonmelanoma skin cancer 59 mycophenolic acid 59 OvaRex ® MAb 59 Pertuzumab 59 aripiprazole Abilify 59 ovarian lung 59 therapeutic regimens 59 paclitaxel poliglumex 59 cell carcinoma RCC 59 Gemzar ® 59 colorectal neoplasms 59 haematological malignancies 59 recurrent bladder 59 iniparib BSI 59 diffuse intrinsic pontine glioma 59 prostate cancer CaP 59 Systemic lupus erythematosus SLE 59 acute promyelocytic leukemia 59 Alimta 59 Panzem R 59 neuroendocrine tumors 59 Hormonal therapy 59 Edurant 59 biologic antibody 59 Candida infection 59 TMP SMX 59 divalproex sodium 59 interstitial pneumonia 59 lymphoblastic leukemia 59 dacarbazine 59 dexpramipexole 59 Prednisone Against Refractory 59 refractory NSCLC 59 mCRC patients 59 Radical prostatectomy 59 PREZISTA r 59 tamoxifen citrate 59 squamous histology 59 malignant neoplasms 59 Cremophor 59 Omacetaxine 59 Squamous cell 59 Canvaxin 59 relapsed GBM 59 precancerous cervical lesions 59 Carboplatin 59 lichen planus 59 OHR/AVR# 59 chemoresistant 59 pharmacologic therapies 59 Taxol ® 59 FOLFIRINOX 59 carboplatin paclitaxel 59 trastuzumab Herceptin 59 refractory angina 59 relapsed AML 59 idiopathic thrombocytopenic purpura ITP 59 anti leukemic 59 IRESSA 59 immunocompetent adults 59 pazopanib 59 type 1diabetes 59 tumor lysis syndrome 59 pediatric malignancies 59 Etravirine 59 combination antiretroviral therapy 59 dose dexamethasone 59 anticancer therapies 59 Mabthera 59 thromboembolisms 59 advanced carcinoid 59 Malignant Glioma 59 commercialize deforolimus 59 T1DM 59 LymphoStat B belimumab 59 superficial bladder cancer 59 dermatofibrosarcoma protuberans 59 squamous cell cancers 59 histologic subtype 59 myeloid leukemia 59 tyrosine kinase inhibitors 59 dual endothelin receptor antagonist 59 cutaneous T 59 B CLL 59 Pseudomonas aeruginosa infections 59 azacytidine 59 quetiapine Seroquel 59 daunorubicin 59 efaproxiral 59 DCVax Brain 59 KRAS mutations occur 59 JAK mutations 59 Inhaled nitric oxide 59 squamous cell carcinoma SCC 59 HuLuc# 59 nasopharyngeal cancer 59 refractory multiple myeloma 59 FOLFIRI 59 Soft Tissue Sarcoma 59 venous thromboembolic events 59 T DM1 59 irinotecan containing 59 radioiodine therapy 59 regorafenib 59 MELAS 59 micafungin 59 samalizumab 59 psoriasis rheumatoid arthritis 59 hormonally sensitive 59 benign prostatic hypertrophy BPH 59 ovarian breast 59 pharyngeal cancer 59 Oesophageal cancer 59 treating cancerous tumors 59 peginterferon alfa 59 IV melanoma 59 angiogenesis inhibition 59 lobular cancer 59 RET PTC rearrangements 59 MYLOTARG 59 proteasome inhibitors 59 rheumatoid arthritis psoriatic arthritis 59 cholinesterase inhibitor 59 perioperatively 59 metastatic androgen independent 59 antirheumatic 59 SCIg 59 imatinib resistant 59 mTOR inhibition 59 clodronate 59 oral JAK1 59 Aptivus ® 59 Gliadel Wafer 59 T#I [002] 59 OSI Tarceva 59 Daclizumab 59 Adjuvant therapy 59 unresectable liver cancer 59 soft tissue sarcomas 59 disease modifying antirheumatic 59 Elotuzumab 59 heterozygous FH 59 metastatic HER2 negative 59 secondary amenorrhea